Clinical Trial

Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial

Study acronym: ADVANCE
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this trial is to generate clinical evidence related to key performance outcomes of Endurant II/IIs Stent Graft Systems verses Gore Excluder / Excluder Conformable AAA Endoprosthesis in subjects with Abdominal Aortic Aneurysms. Subjects are randomized and imaging collected at all follow-up time points to assess the primary endpoint.
Protocol Amendment History 29 amendments
This ClinicalTrials.gov record has been amended 29 times since 2022-05-12; most recent amendment 2026-07-01.
Status change: Not Yet Recruiting → Recruiting 2022-08-18
Trial Details
NCT Number NCT05378347
Lead Sponsor Medtronic Cardiovascular
Conditions Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder), Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder)
Enrollment 600 participants
Start Date 2023-01-05
Primary Completion 2027-05 (estimated)
Study Completion 2031-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-06